Artelo Biosciences, Inc. (ARTL)
NASDAQ: ARTL · IEX Real-Time Price · USD
1.480
-0.010 (-0.67%)
At close: Mar 28, 2024, 2:45 PM
1.500
+0.020 (1.35%)
After-hours: Mar 28, 2024, 7:54 PM EDT

Artelo Biosciences Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Year 2023202220212020201920182017201620152014
Cash & Equivalents
2.826.896.632.144.420.340.5700.020.01
Short-Term Investments
7.6110.653.440000000
Cash & Cash Equivalents
10.4317.5310.072.144.420.340.5700.020.01
Cash Growth
-40.53%74.20%369.89%-51.58%1205.30%-40.83%15854.74%-78.92%15.60%-
Receivables
000000.020000
Other Current Assets
0.550.790.250.20.020.040000
Total Current Assets
10.9818.3210.322.344.440.40.5700.020.01
Property, Plant & Equipment
0.020.060.090000000
Goodwill and Intangibles
2.042.042.042.042.0400000
Other Long-Term Assets
000.190000000
Total Long-Term Assets
2.062.12.322.042.0400000
Total Assets
13.0420.4212.644.386.480.40.5700.020.01
Accounts Payable
1.270.960.50.50.350.530.030.0200
Current Debt
0.020.040.030000000
Other Current Liabilities
00000.6700000
Total Current Liabilities
1.2910.530.51.020.530.030.0200
Long-Term Debt
00.020.070000000
Total Long-Term Liabilities
00.020.070000000
Total Liabilities
1.291.020.590.51.020.530.030.0200
Total Debt
0.020.060.10000000
Debt Growth
-63.49%-33.68%--------
Retained Earnings
-40.31-31.02-16.9-9.47-4.81-2.64-0.3-0.06-0.03-0.02
Comprehensive Income
-0.2-0.250.020.06-0.01-0.010000
Shareholders' Equity
11.7519.412.043.885.46-0.130.54-0.010.020.01
Net Cash / Debt
10.417.479.972.144.420.340.5700.020.01
Net Cash / Debt Growth
-40.45%75.23%365.45%-51.58%1205.30%-40.83%15854.74%-78.92%15.60%-
Net Cash Per Share
3.516.178.018.6730.553.985.900.040.240.43
Working Capital
9.6917.329.791.843.42-0.140.54-0.010.020.01
Book Value Per Share
3.976.859.6715.6837.71-1.585.62-0.160.210.43
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).